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doi:10.1016/j.ejvs.2010.04.002Abstract Objectives: Single centre series have suggested that endovascular aneurysm repair
(EVAR) for ruptured abdominal aortic aneurysms (rAAA) may reduce mortality versus open
surgery. This has not been substantiated in the only randomized controlled trial, leading to
suggestion that anatomical suitability for rEVAR may independently improve prognosis of rAAA.
Our aim was to assess the outcome of open rAAA repair in patients dependant on their suit-
ability for rEVAR on pre-operative computed tomography (CT) assessment.
Methods: A retrospective review of all ruptured aneurysms presenting to our unit since
January 1998 was performed. Patients were grouped based on anatomical suitability for rEVAR
by pre-operative CT.
Results: Of 118 patients presenting with rAAA, 48 underwent pre-operative CT. Of these 9 scans
hadbeen “culled” andwere excluded. 16 patientswere suitable for rEVAR and 23 unsuitable. The
groups were well matched demographically with no difference in Glasgow Aneurysm Score
between groups. There was a non-significant trend towards reduction in 30-day mortality for
patients suitable for EVAR (suitable 6.9% versus unsuitable 30.4%; PZ 0.066) with no difference
in operative time, transfusion requirement, length of stay or in-hospital morbidity.
Conclusions: Anatomical suitability for EVAR seems to beneficially affect outcome following
open repair for ruptured AAA. Further study is required to confirm these findings.
Crown Copyright ª 2010 Published by Elsevier Ltd on behalf of European Society for Vascular
Surgery. All rights reserved.dge, MBBS, FRACS(vasc), Consultant Vascular Surgeon, Department of Vascular Surgery, Flinders
rd Park, SA5042, Australia. Tel.: þ61 (8) 8204 5445; fax: þ61 (8) 8204 7106.
health.sa.gov.au (P.J. Puckridge).
10 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. All rights reserved.
Outcome of Ruptured AAA and Aortic Morphology 187Introduction
Mortality following open repair of ruptured abdominal
aortic aneurysm (rAAA) remains high.1,2 There has only
been minor improvement in mortality over the last 40e50
years and 30-day mortality is now thought to be 41%3 Many
suggest that as there has been minimal change an alter-
native approach to treatment for rAAA should be sought.
Endovascular repair of AAA has emerged as a less invasive
approach to elective AAA repair with proven benefits of
reduced peri-operative morbidity and mortality.4,5 Endo-
vascular repair of rAAA (rEVAR) has been reported and is
felt to be a feasible technique.6 Consequently many
centres have taken on rEVAR with enthusiasm. Evidence for
rEVAR comes from single centre case series, systematic
reviews and population data, with retrospective and
prospective studies comparing outcomes with current or
historical controls. Overall reported mortality has varied
with mean 30-day mortality being 18% (range 0e53%).6 Only
one published randomized controlled trial exists with no
statistical benefit found from endovascular repair.7
Endovascular repair is only possible if patients have
appropriate anatomical morphology. These anatomical
features may make open surgery simpler in elective and
ruptured cases. It currently remains unclear whether the
reported improved outcomes in mortality with rEVAR are
related to patient selection bias, procedural or anatomical
features. In order to test the hypothesis that outcomes are
related to anatomical rather than procedure benefits
a single centre retrospective review assessing anatomical
suitability for endovascular repair was performed for
patients presenting with rAAA.Methods
Ethics committee approval was obtained from the institu-
tional bodies of the participating hospitals. A retrospective
review was performed of all patients undergoing surgical
repair of rAAA at the Repatriation General Hospital and
Flinders Medical Centre, South Australia, from January 1998
to May 2009. Patients were identified from prospectively
collected Vascular Surgery Departmental database and
compared to computerized operating theatre records for
completeness. Patients undergoing computed tomography
(CT) imaging prior to repair of rAAA were identified.
Pre-operative CT imaging was assessed by a single blin-
ded author for EVAR suitability. Anatomical suitability for
EVAR was determined for endovascular devices currently
used at the Repatriation General Hospital and Flinders
Medical Centre as of May 2009. Criteria for suitability
included aortic neck diameter of 18e32 mm, neck length
15 mm, neck angulation <60, iliac diameter of
7.5e20 mm, length of iliac sealing zone 10 mm and overall
aneurysm length of >82 mm. Relative contraindications to
endovascular repair such as thrombus load within the aortic
neck were not considered.
Demographic information collected included age,
gender, and co-morbidities. The primary outcomes were
30-day or in-hospital mortality. Secondary outcomes
included procedural length, transfusion requirements,
morbidity, length of stay, and change to a requirement forsupportive care following discharge. The Glasgow Aneurysm
Score (GAS) was calculated using demographic data and
data collected from medical records as a measure of risk
and expected outcome following rAAA.8
Descriptive statistics were calculated for all variables.
A one sample KolmogoroveSmirnov test confirmed contin-
uous data to conform to normal distribution and it has thus
been reported as mean  standard deviation. Categorical
data is reported as percentages. Chi squared and Fishers
exact tests were used as appropriate to test for differences
in categorical data between groups. The unpaired student
t-test was utilised for continuous data. Intra-operative
deaths were excluded from length of stay analysis. Statis-
tical significance was defined as P value  0.05. All analyses
were performed using SPSS for Windows version 12.0
(SPSS, Chicago, Illinois, USA)
Results
118 patients were identified as undergoing open repair of
rAAA from Jan 1998 to July 2009. 48 (41%) had a CT scan
pre-operatively and 70 (59%) patients were transferred
immediately to the operating theatre. 1 patient during the
same period underwent rEVAR and was excluded from this
analysis. 9 CT scans were unavailable for review as they had
been culled from South Australian state radiology storage
facilities leaving 39 scans available for review. These 39
patients constituted the study dataset with 16 patients
identified as “suitable” for endovascular repair and 23 as
“not suitable” on anatomical criteria.
There were demographic differences between patients
who had a CT scan pre-operatively and those who were
transferred to theatre without a CT. Patients undergoing CT
scan pre-operatively were significantly more likely to have
chronic obstructive airways disease (COAD), documented
heart failure and renal impairment, while patients not
having a CT were more likely to have had previous coronary
artery surgery. There was no difference in current medical
therapy or calculated Glasgow Aneurysm score between the
two groups. Analysis of the group undergoing CT scan pre-
operatively demonstrated no significant differences in
demographics, medication usage or calculated Glasgow
Aneurysm score between those considered suitable and not
suitable for rEVAR (Table 1).
Overall 30-day mortality following ruptured AAA was
29.7% (35/118). There was no significant difference in 30-
day mortality between patients having a CT prior to repair
and not (20.8% [10/48] versus 35.7% [25/70]; P Z 0.082).
30-day and in-hospital mortality were the same.
There was a trend towards reduced 30-day mortality in
patients suitable for rEVAR (Table 2). Patients who were
suitable for rEVAR had reduced procedural length, trans-
fusion requirements and morbidity, but the differences
were not statistically significant (Table 3). There was no
difference in discharge destination between those suitable
and not suitable for rEVAR.
Discussion
The primary aim of rEVAR for rAAA is an improvement in
immediate outcome and 30-day mortality. Reduction in
Table 1 Demographics, medications and calculated Glasgow Aneurysm Scores for patients with ruptured AAA. SD, Standard
deviation.
All ruptured AAA Preo-perative CT evaluated patients according
to suitability for EVAR
No CT
N Z 70(%)
CT scan
N Z 48(%)
P value Suitable
N Z 16(%)
Not suitable
N Z 23(%)
P value
Mean age 76.3  7.1SD 76.7  8.0SD 0.745 78.7  6.3SD 77.0  9.2SD 0.520
Gender (% male) 63 (90%) 38 (79%) 0.100 11 (68%) 19 (82%) 0.312
Hypertension 41 (59%) 35 (73%) 0.110 12 (75%) 15 (65%) 0.515
Hyper-cholesterolaemia 14 (20%) 9 (19%) 0.866 3 (19%) 6 (26%) 0.593
COAD 11 (16%) 18 (38%) 0.007 8 (50%) 7 (30%) 0.217
IHD 22 (31%) 15 (31%) 0.984 5 (31%) 7 (30%) 0.957
Previous CABG 12 (17%) 1 (2%) 0.010 0 (0%) 0 (0%) N/A
CCF 3 (4%) 7 (15%) 0.048 4 (25%) 2 (9%) 0.165
Cerebrovascular disease 7 (10%) 6 (13%) 0.670 2 (13%) 4 (17%) 0.677
CRF 3 (4%) 8 (17%) 0.023 3 (19%) 5 (22%) 0.820
Aspirin 22 (31%) 13 (27%) 0.612 5 (31%) 6 (26%) 0.725
Warfarin 4 (6%) 7 (15%) 0.119 3 (19%) 4 (17%) 1.000
Statin 19 (27%) 7 (15%) 0.612 3 (19%) 4 (17%) 1.000
ACE inhibitor 15 (21%) 15 (31%) 0.229 5 (31%) 6 (26%) 0.725
Beta-blocker 15 (21%) 9 (19%) 0.723 2 (13%) 6 (26%) 0.432
Glasgow Aneurysm Score 94.5  13.8SD 92.1  17.0SD 0.395 93.4  20.2SD 92.3  14.6SD 0.854
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length of stay without significant increases in cost are
important secondary goals. Currently the evidence for this
is lacking. This study has demonstrated that mortality
following open repair of ruptured AAA is reduced if the
patient has anatomy suitable for endovascular repair.
Mortality differences of such a large scale, due to
anatomical differences, have not been previously reported.
Interestingly in this series of patients the expected
mortality was over 50% for both patients suitable and not
suitable for endovascular repair as determined by the GAS,
which is a well validated tool for predicting mortality
following ruptured AAA.8 The similar demographic and
calculated GAS scores reinforce that physiological status
between the groups were similar. The only difference
between the two groups identified was the anatomical
differences reinforcing the argument that anatomical
factors influence the postoperative outcome.
The published mortality benefits ascribed to EVAR in
ruptured AAA have been shown in studies when compared
to historical and prospective controls.9,10 A reduction in
mortality has also been demonstrated in population based
studies from the USA.9 The one prospective randomized
controlled trial did not have any mortality benefit.7 There
are many bias’s amongst historical and prospective non-
randomized controls. Both groups include those not suit-
able for EVAR, which would potentially skew results
towards implicating EVAR in rAAA as reducing mortality.
The results of this study, suggesting that anatomicalTable 2 30 Day mortality following ruptured AAA depending on
Suitable n Z 16 (%)
30-day mortality 1 (6.9%)differences may influence outcome, suggest that pop-
ulation based research is similarly flawed.
rEVAR has also been associated with a reduction in
transfusion requirements and length of ICU stay.7,11e21
Similarly this study has demonstrated a reduction in
transfusion requirements when patients are suitable for
rEVAR but treated by open repair. The anatomical
morphology may be associated with better outcomes due to
simpler surgery rather than the technique of endovascular
repair itself.
Slater et al. report similar findings to this study, with
a trend towards decreased mortality following open repair
of rAAA if the patient was suitable on CT for rEVAR. Their
series had demographic differences which make compar-
ison and extrapolation of the data more difficult. However
outcomes for both 30-day and 1 year mortality were
improved in the rEVAR suitable group. They also demon-
strated that length of stay and ability to be discharged
home were affected by anatomical differences, suggesting
that anatomy allowing for rEVAR provides a technically
easier operation with better outcomes.22 In combination
with our series this provides an increasing body of evidence
suggesting that the patients anatomical morphology is an
important predictor of outcome.
The small sample size of this study limits applicability,
but does justify further research. Although the study is
retrospective, outcomes following rEVAR are frequently
compared to historical controls. Consequently the authors
felt it was relevant to distinguish the outcomes of patientssuitability for EVAR.
Not suitable n Z 23 (%) P value
7 (30.4%) 0.066
Table 3 Secondary outcomes following ruptured AAA for patients with pre-operative CT evaluation. SD, Standard deviation.
Suitable N Z 16 (%) Not suitable N Z 23 (%) P value
Procedural length 170.8  65.5SD 190.7  78.8SD 0.414
Transfusion requirements (units) 7.7  5.1SD 9.6  6.9SD 0.361
Length of stay (days) 24.3  20.0SD 20.9  16.3SD 0.562
In-hospital morbidity 13 (79%) 21 (91%) 0.356
Outcome of Ruptured AAA and Aortic Morphology 189prior to the implementation of rEVAR programs. Endovas-
cular repair of rAAA costs an average of US$11,372 more per
patient than open repair.23 As implementation of rEVAR
programs for rAAA is expensive, determination of the val-
idity of potential benefits is required.
Anatomical suitability alone appears to reduce mortality
following open repair of rAAA. Thus, the concept that the
less invasive technique of rEVAR independently improves
outcomes in rAAA versus open repair may be flawed.
A randomized controlled trial would be necessary to
determine benefit of rEVAR. There are multiple difficulties
in establishing such a trial, and to allow for anatomical
differences predicting outcome the trial must be performed
randomizing those suitable for EVAR to open or endovas-
cular repair. The AJAX and ECAR trials may provide addi-
tional information as they randomize after CT assessment if
stable, but are relatively small.24,25 Unfortunately the
larger, currently recruiting IMPROVE trial is not specifically
going to address this issue, as those who are deemed suit-
able will undergo EVAR wherever possible. IMPROVE aims to
address the issue as to whether an endovascular first
strategy is associated with improved survival or it intro-
duces delays leading to adverse clinical consequences.25
In conclusion anatomical suitability for EVAR seems to
beneficially affect outcome following open repair for
ruptured AAA. Mortality is markedly lower, but further
study is required to confirm these findings.Conflict of Interest/Funding
None.
References
1 Visser P, Akkersdijk GJM, Blankensteijn JD. In-hospital opera-
tive mortality of ruptured abdominal aortic aneurysm: a pop-
ulation-based analysis of 5593 patients in The Netherlands over
a 10-year period. Eur J Vasc Endovasc Surg 2005;30:359e64.
2 Heller JA, Weinberg A, Arons R, Krishnasastry KV, Lyon RT,
DeitchJS,etal.Twodecadesofabdominalaorticaneurysmrepair:
have we made any progress? J Vasc Surg 2000;32:1091e100.
3 Bown MJ, Sutton AJ, Bell PRF, Sayers RD. A meta-analysis of 50
years of ruptured abdominal aortic aneurysm repair. Br J Surg
2002;89:714e30.
4 Greenhalgh RM, Brown LC, Kwong GPS, Powell JT,
Thompson SG. Comparison of endovascular aneurysm repair
with open repair in patients with abdominal aortic aneurysm
(EVAR trial 1), 30-day operative mortality results: randomised
controlled trial. Lancet 2004;364:843e8.
5 Prinssen M, Verhoeven ELG, Buth J, Cuypers P, van
Sambeek MRHN, Balm R, et alfor the DREAM Trial Group.
A randomized trial comparing conventional and endovascularrepair of abdominal aortic aneurysms. N Eng J Med 2004;351:
1607e18.
6 Harkin DW, Dillon M, Blair PH, Ellis PK, Kee F. Endovascular
ruptured abdominal aortic aneurysm repair (EVRAR): A
systematic review. Eur J Vasc Endovasc Surg 2007;34:673e81.
7 Hinchcliffe RJ, Bruijstens L, MacSweeney STR, Braithwaite BD.
A randomised trial of endovascular and open surgery for
ruptured abdominal aortic aneurysm e results of a pilot study
and lessons learned for future studies. Eur J Vasc Endovasc Surg
2006;32:506e13.
8 Korhonen SJ, Ylonen K, Biancari F, Heikkinen M, Salenius J-Pfor
the Finnvasc Study Group. Glasgow Aneurysm Score as
a predictor of immediate outcome after surgery for ruptured
abdominal aortic aneurysm. Br J Surg 2004;91:1449e52.
9 Hinchcliffe RJ, Powell JT, Cheshire NJ, Thompson MM. Endovas-
cular repair of ruptured abdominal aortic aneurysm: a strategy in
need of definitive evidence. J Vasc Surg 2009;49:1077e80.
10 Rayt HS, Sutton AJ, London NJM, Sayers RD, Brown MJ.
A systematic review and meta-analysis of endovascular repair
(EVAR) for ruptured abdominal aortic aneurysm. Eur J Vasc
Endovasc Surg 2008;36:536e44.
11 Peppelenbosch N, Yilmaz N, van Marrewijk C, Buth J, Cuypers P,
Duijm L, et al. Emergency treatment of acute symptomatic or
ruptured abdominal aortic aneurysm. Outcome of a prospective
intent-to-treat by EVAR protocol. Eur J Vasc Endovasc Surg
2003;26:303e10.
12 Resch T, Malina M, Lindblad B, Dias NV, Sonesson B, Ivancev K,
et al. Endovascular repair of ruptured abdominal aortic aneu-
rysms: logistics and short-term results. J Endovasc Ther 2003;
10:440e6.
13 Alsac JM, Desgranges P, Kobeiter H, Becquemin JP. Emergency
endovascular repair for ruptured abdominal aortic aneurysms:
feasibility and comparison of early results with conventional
open repair. Eur J Vasc Endovasc Surg 2005;30:632e9.
14 Brandt M, Walluscheck KP, Jahnke T, Graw K, Cremer J,
Muller-Hulsbeck S, et al. Endovascular repair of ruptured
abdominal aortic aneurysm: feasibility and impact on early
outcome. J Vasc Interv Radiol 2005;16:1309e12.
15 Franks S, Lloyd G, Fishwick G, Bown M, Sayers R. Endovascular
treatment of ruptured and symptomatic abdominal aortic
aneurysms. Eur J Vasc Endovasc Surg 2006;31:345e50.
16 Kapma MR, Verhoven EL, Tielliu IF, Zeebregts CJ, Prins TR,
Vander HB, et al. Endovascular treatment of acute abdominal
aortic aneurysm with a bifurcated stentgraft. Eur J Vasc Endo-
vasc Surg 2005;29:510e5.
17 Ohki T, Veith FJ. Endovascular grafts and other image-guided
catheter-based adjuncts to improve the treatment of ruptured
aortoiliac aneurysms. Ann Surg 2000;232:466e79.
18 Reichart M, Geelkerken RH, Huisman AB, van Det RJ, de Smit P,
Volker EP, et al. Ruptured abdominal aortic aneurysm: endo-
vascular repair is feasible in 40% of patients. Eur J Vasc Endo-
vasc Surg 2003;26:479e86.
19 Vaddineni SK, Russo GC, Patterson MA, Taylor SM, Jordan Jr WD.
Ruptured abdominal aortic aneurysm: a retrospective assessment
ofopenversusendovascular repair.AnnVasc Surg2005;19:782e6.
20 Verhoven EL, Prins TR, van den Dungen JJ, Tielliu IF,
Hulsebos RG, van Schilfgaarde R, et al. Endovascular repair of
190 S. Perrott et al.acute AAAs under local anesthesia with bifurcated endografts:
a feasibility study. J Endovasc Ther 2002;9:729e35.
21 Yilmaz N, Peppelenbosch N, Cuypers PW, Tielbeek AV,
Duijm LE, Buth J, et al. Emergency treatment of symptomatic
or ruptured abdominal aortic aneurysms: the role of endovas-
cular repair. J Endovasc Ther 2002;9:449e57.
22 Slater BJ, Harris EJ, Lee JT. Anatomic suitability of ruptured
abdominal aortic aneurysms for endovascular repair. Ann Vasc
Surg 2008;22(6):716e22.23 Vogel TR, Dombrovskiy V, Haser P, Graham A. Has the imple-
mentation of EVAR for ruptured AAA improved outcomes? Vasc
Endovascular Surg 2009;43:252e7.
24 Amsterdam Acute Aneurysm Trial Collaborators. Amsterdam
acute aneurysm trial; background design and methods. Vascular
2006;14:1e6.
25 Powell JT. Time to IMPROVE the management of ruptured
abdominal aortic aneurysm: IMPROVE trialists. Eur J Vasc
Endovasc Surg 2009;38:237e8.
